| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | NVDA | United States | $176.92 | $187,142,000,000.00 | Strong Buy | 39 | 1999 |
#2 | ORCL | United States | $201.35 | $59,018,000,000.00 | Buy | 31 | 1986 |
#3 | NFLX | United States | $107.43 | $43,378,787,000.00 | Buy | 34 | 2002 |
#4 | ARM | United Kingdom | $134.44 | $4,412,000,000.00 | Strong Buy | 24 | 2023 |
#5 | PDD | Ireland | $115.82 | $58,790,822,784.00 | Buy | 10 | 2018 |
#6 | NET | United States | $199.81 | $2,013,376,000.00 | Buy | 27 | 2019 |
#7 | TEL | Ireland | $225.94 | $17,262,000,000.00 | Buy | 11 | 2007 |
#8 | MSTR | United States | $176.40 | $474,942,000.00 | Strong Buy | 15 | 1998 |
#9 | ZS | United States | $250.90 | $2,833,272,000.00 | Buy | 34 | 2018 |
#10 | LHX | United States | $278.29 | $21,740,000,000.00 | Buy | 17 | N/A |
#11 | VEEV | United States | $241.36 | $3,080,246,000.00 | Buy | 29 | 2013 |
#12 | RKLB | United States | $42.06 | $554,535,000.00 | Buy | 14 | N/A |
#13 | CYBR | Israel | $456.94 | $1,302,851,000.00 | Buy | 31 | 2014 |
#14 | BE | United States | $108.36 | $1,818,704,000.00 | Buy | 19 | 2018 |
#15 | NTNX | United States | $47.71 | $2,617,547,000.00 | Buy | 16 | 2016 |
#16 | DKS | United States | $205.80 | $14,882,715,000.00 | Buy | 20 | N/A |
#17 | ACM | United States | $102.96 | $16,139,622,000.00 | Strong Buy | 10 | 2007 |
#18 | J | United States | $135.04 | $12,029,783,000.00 | Buy | 10 | N/A |
#19 | MDB | United States | $332.14 | $2,218,189,000.00 | Strong Buy | 36 | 2017 |
#20 | WMG | United States | $28.17 | $6,707,000,000.00 | Buy | 14 | 2020 |
#21 | AVAV | United States | $278.79 | $1,085,820,000.00 | Strong Buy | 14 | 2007 |
#22 | IREN | Australia | $47.88 | $688,554,000.00 | Buy | 11 | 2021 |
#23 | RGTI | United States | $25.65 | $7,494,000.00 | Strong Buy | 5 | N/A |
The FinQuota filters have identified what they believe to be the "Best Undervalued Blue Chip Stocks of December 2025" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.